Advertisement Perrigo enters deal with Founder Group to expand infant formula distribution in China - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Perrigo enters deal with Founder Group to expand infant formula distribution in China

Perrigo Company has entered into an agreement with Founder Pharma, a subsidiary of Southwest Synthetic Pharmaceutical to supply infant formula manufactured in its US facilities.

The product will be sold and distributed by Founder Pharma in China.

Perrigo chairman and CEO Joseph C Papa said Synthetic’s strong brand, marketing, and distribution would help them grow in the robust infant formula market.

Perrigo Company develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API).